Initiator Pharma A/S — Credit Rating and Financial Key Figures
Credit rating
Company information
About Initiator Pharma A/S
Initiator Pharma A/S (CVR number: 37663808) is a company from KØBENHAVN. The company recorded a gross profit of -23413 kDKK in 2023. The operating profit was -27 mDKK, while net earnings were -22.9 mDKK. The profitability of the company measured by Return on Assets (ROA) was -69.2 %, which can be considered poor and Return on Equity (ROE) was -101.2 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 37.5 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. Initiator Pharma A/S's liquidity measured by quick ratio was 9.3 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | -8 366.00 | -21 626.00 | -38 425.00 | -23 413.00 | |
EBIT | -9 339.00 | -10 531.00 | -23 072.00 | -41 740.00 | -27 030.00 |
Net earnings | -8 288.00 | -8 697.00 | -21 064.00 | -38 455.00 | -22 873.00 |
Shareholders equity total | 9 908.00 | 14 409.00 | 34 994.00 | 34 023.00 | 11 162.00 |
Balance sheet total (assets) | 11 438.00 | 15 603.00 | 53 701.00 | 48 345.00 | 29 786.00 |
Net debt | -7 562.00 | -21 056.00 | -26 535.00 | -8 899.00 | |
Profitability | |||||
EBIT-% | |||||
ROA | -64.9 % | -77.9 % | -66.6 % | -81.8 % | -69.2 % |
ROE | -62.6 % | -71.5 % | -85.3 % | -111.4 % | -101.2 % |
ROI | -70.5 % | -86.6 % | -73.6 % | -88.0 % | -73.9 % |
Economic value added (EVA) | -7 864.08 | -9 062.04 | -20 769.78 | -37 071.08 | -22 690.39 |
Solvency | |||||
Equity ratio | 86.6 % | 46.2 % | 65.2 % | 70.4 % | 37.5 % |
Gearing | 38.0 % | 37.0 % | 138.3 % | ||
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 7.5 | 7.1 | 26.5 | 9.3 | |
Current ratio | 7.5 | 9.9 | 27.7 | 9.3 | |
Cash and cash equivalents | 7 562.00 | 34 346.00 | 39 112.00 | 24 336.00 | |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | BB | BBB | BB | BBB | BBB |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.